GoodRx Holdings Inc (GDRX)
7.465
+0.36
(+5.14%)
USD |
NASDAQ |
May 06, 16:00
7.465
0.00 (0.00%)
After-Hours: 19:08
GoodRx Holdings Enterprise Value: 2.789B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | 2.789B |
May 02, 2024 | 2.753B |
May 01, 2024 | 2.737B |
April 30, 2024 | 2.789B |
April 29, 2024 | 2.808B |
April 26, 2024 | 2.824B |
April 25, 2024 | 2.781B |
April 24, 2024 | 2.733B |
April 23, 2024 | 2.737B |
April 22, 2024 | 2.615B |
April 19, 2024 | 2.627B |
April 18, 2024 | 2.643B |
April 17, 2024 | 2.552B |
April 16, 2024 | 2.560B |
April 15, 2024 | 2.571B |
April 12, 2024 | 2.682B |
April 11, 2024 | 2.718B |
April 10, 2024 | 2.749B |
April 09, 2024 | 2.646B |
April 08, 2024 | 2.686B |
April 05, 2024 | 2.710B |
April 04, 2024 | 2.635B |
April 03, 2024 | 2.639B |
April 02, 2024 | 2.670B |
April 01, 2024 | 2.789B |
Date | Value |
---|---|
March 28, 2024 | 2.789B |
March 27, 2024 | 2.753B |
March 26, 2024 | 2.773B |
March 25, 2024 | 2.777B |
March 22, 2024 | 2.583B |
March 21, 2024 | 2.650B |
March 20, 2024 | 2.670B |
March 19, 2024 | 2.571B |
March 18, 2024 | 2.579B |
March 15, 2024 | 2.714B |
March 14, 2024 | 2.658B |
March 13, 2024 | 2.804B |
March 12, 2024 | 2.836B |
March 11, 2024 | 2.887B |
March 08, 2024 | 2.903B |
March 07, 2024 | 2.962B |
March 06, 2024 | 2.974B |
March 05, 2024 | 2.990B |
March 04, 2024 | 3.176B |
March 01, 2024 | 3.282B |
February 29, 2024 | 3.061B |
February 28, 2024 | 2.540B |
February 27, 2024 | 2.587B |
February 26, 2024 | 2.567B |
February 23, 2024 | 2.504B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.540B
Minimum
Nov 09 2022
22.63B
Maximum
Sep 28 2020
7.660B
Average
2.828B
Median
Enterprise Value Benchmarks
Sharecare Inc | 141.72M |
American Well Corp | -124.99M |
MultiPlan Corp | 4.896B |
Privia Health Group Inc | 1.878B |
GeneDx Holdings Corp | 453.51M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -25.87M |
Revenue (Quarterly) | 196.64M |
Total Expenses (Quarterly) | 214.93M |
EPS Diluted (Quarterly) | -0.06 |
Gross Profit Margin (Quarterly) | 92.29% |
Profit Margin (Quarterly) | -13.16% |
Earnings Yield | -0.27% |
Normalized Earnings Yield | -0.2679 |